| [1] Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:Sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):E359-386.[2] Snaith A,El-Omar EM.Helicobacter pylori:host genetics and disease outcomes[J].Expert Rev Gastroenterol Hepatol,2008,2(4):577-585.[3] Zhou J,Liu ZY,Li CB,et al.Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer[J].Tumour Biol,2014,36(4):3017-3023.[4] Ksiaa F,Ziadi S,Dhiab MB,et al.Increased DNA methyltransferase 1 protein expression correlates significantly with intestinal histological type and gender in gastric carcinomas[J].Adv Med Sci,2014,60(1):50-57.[5] Shi J F,Li XJ,Si XX,et al.ERalpha positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells[J].Biochem Biophys Res Commun,2012,427(1):47-53.[6] Sun MY,Yang XX,Xu WW,et al.Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China[J].Genet Mol Res,2012, 11(4):4330-4341.[7] Mostowska A,Sajdak S,Pawlik P,et al.DNMT1,DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population[J].Mol Biol Rep,2013,40(8):4893-4899.[8] De La Vega FM.Selecting single-nucleotide polymorphisms for association studies with SNP browser software[J].Methods Mol Biol,2007,376:177-193.[9] Jeltsch A.Molecular enzymology of mammalian DNA methyltransferases[J].Curr Top Microbiol Immunol,2006,301:203-225.[10] Subramaniam D,Thombre R,Dhar A,et al.DNA methyltransferases:a novel target for prevention and therapy[J].Front Oncol,2014,4:80.[11] Dhe-Paganon S,Syeda F,Park L.DNA methyl transferase 1:regulatory mechanisms and implications in health and disease [J].Int J Biochem Mol Biol,2011,2(1):58-66.[12] Singh V,Sharma P,Capalash N.DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer [J].Curr Cancer Drug Targets,2013,13(4):379-399.[13] Tang H,Deng M,Tang Y,et al.miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression [J].Clini Cancer Res,2013,19(20):5602-5612.[14] Xu Z,Taylor JA.SNPinfo:integrating GWAS and candidate gene information intofunctional SNP selection for genetic association studies[J].Nucleic Acids Res,2009,37(Web Server issue):W600-605.[15] Lee PH, Shatkay H.F-SNP:computationally predicted functional SNPs for disease association studies[J].Nucleic Acids Res,2008,36(suppl 1):D820-D824.[16] Mostowska A,Sajdak S,Pawlik P,et al.DNMT1,DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population [J].Mol Biol Rep,2013,40(8):4893-4899.[17] Ye C,Beeghly-Fadiel A,Lu W,et al.Two-stage case-control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk[J].Breast Cancer Res Treat,2010,121(3):765-769.[18] Jiang J,Jia Z,Cao D,et al.Polymorphisms of the DNA methyltransferase 1 associated with reduced risks of Helicobacter pylori infection and increased risks of gastric atrophy[J].PLoS One,2012,7(9):e46058.[19] 孙 婷,李 平,张 梅.晚期胃癌维持治疗现状[J].吉林中医药,2014,34(10):1077-1080. |
